Administration of myo-inositol plus ethanolamine elevates phosphatidylethanolamine plasmalogen in the rat cerebellum

Neurochemical Research

Volumn 30, Issue 1, 2005, Pages 47-60

  Hoffman Kuczynski, Beth ^a,b   Reo, Nicholas V ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain myo inositol; Brain phospholipid metabolism; NMR brain phospholipids; Plasmalogens

Indexed keywords

CARBON 13; ETHANOLAMINE; INOSITOL; LIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PLASMALOGEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; HIPPOCAMPUS; ISOTOPE LABELING; LIPID METABOLISM; MALE; MESENCEPHALON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; CEREBELLUM; DRUG COMBINATIONS; ETHANOLAMINE; INOSITOL; MALE; PLASMALOGENS; RATS; RATS, INBRED F344;

EID: 13844291268     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-9685-4     Document Type: Article

References (37)

1. Brosche, T. 1997. Plasmalogen phospholipids - facts and theses to their antioxidative qualities. Arch. Gerontol. Geriatr. 25:73-81.
2. Brosche, T. and Platt, D. 1998. The biological significance of plasmalogens in defense against oxidative damage. Exp. Gerontol. 33(5):363-369.
3. Engelmann, B., Brautigam, C., and Thiery, J. 1994. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem. Biophys. Res. Commun. 204(3):1235-1242.
4. Hahnel, D., Beyer, K., and Engelmann, B. 1999. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol. Free Radic. Biol. Med. 27(9/ 10):1087-1094.
5. Hahnel, D., et al. 1999. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem. J. 340:377-383.
6. Khaselev, N. and Murphy, R. C. 1999. Susceptibility of plasmenyl glycerophosphoethanolamine lipids pertaining to oxidative degradation. Free Radic. Biol. Med. 26(3/4):275-284.
7. Ingrand, S. S., et al. 2000. Quantification of long-chain aldehydes by gas chromatography coupled to mass spectrometry as a tool for simultaneous measurements of plasmalogens and their aldehydic breakdown products. Anal. Biochem. 280:65-72.
8. Reiss, D., Beyer, K., and Engelmann, B. 1997. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323:807-814.
9. Sindelar, P. J., Zhiyhong, G., Dallner, G., and Ernster, L. 1999. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26(3/4):318-324.
10. Vagnozzi, R., et al. 1997. Effects of increasing times of incomplete cerebral ischemia upon the energy state and lipid peroxidation in the rat. Exp. Brain Res. 134(3):230-241.
11. Pettegrew, J. W., et al. 2001. Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen. Biol. Psychiatry 49:444-453.
12. Hoffman-Kuczynski, B. and Reo, N. V., 2004. Studies of myo-inositol and plasmalogen metabolism in rat brain. Neurochem. Res. 29(4):843-855.
13. Patishi, Y., et al. 1996. Differential uptake of myo-inositol in vivo into rat brain areas. Eur. Neuropsychopharmacol. 6:73-75.
14. Kofman, O., Agam, G., and Shapiro, J. 1998. Chronic dietary inositol enhances locomotor activity and brain inositol levels in rats. Psychopharmacology 139:239-242.
15. Tyagi, R. K., et al. 1996. Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn. Reson. Med. 35:194-200.
16. 13C NMR spectroscopy. Biochim. Biophys. Acta 1580:171-188.
17. 31P chemical shifts and absolute quantification. Q. Magn. Res. Biol. Med. 3(4):171-176.
18. Horrocks, L. A., et al. 1975. Synthesis and turnover of brain phosphoglycerides - Results, methods of calculation and interpretation Pages 37-54, in Porcellait, G., Luigi, A., and Claudio, G. (eds.), Function and Metabolism of Phospholipids in the Central and Peripheral Nervous Systems. New York: Plenum Press.
19. Miller, S. L., Benjamins, J. A., and Morell, P. 1977. Metabolism of glycerophospholipids of myelin and microsomes in rat brain. J. Biol. Chem. 252(12):4025-4037.
20. Masuzawa, Y., et al. 1984. Turnover rates of the molecular species of ethanolamine plasmalogen of rat brain. J. Neurochcm. 42:961-968.
21. Phillis, J. W., Song, D., and O'Regan, M. H. 1999. Effects of hyperosmolarity and ion substitutions on amino acid efflux from the ischemic rat cerebral cortex. Brain Res. 828:1-11.
22. Marshall, D. L., et al. 1996. Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study. Neurosci. Res. Commun. 18(2):87-96.
23. Baker, R. C. 1987. Disassociation of cerebellar phospholipid composition and acute ethanol effects in mice selectively bred for differential sensitivity to ethanol. Alcohol Drug Res. 7(4):291-299.
24. Snyder, F. 1996. Ether-linked lipids and their bioactive species: occurrence, chemistry, metabolism, regulation and function, Vance, D. E. and Vance, J. E. (eds.), in Biochemistry of Lipids, Lipoproteins and Membranes. New York: Elsevier.
25. Mozzi, R., et al. 1981. The synthesis of choline plasmalogen by the methylation pathway in rat brain. FEBS Lett. 131(1):115-118.
26. Farooqui, A. A. and Horrocks, L. A. 2001. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7(3):232-245.
27. 13C NMR spectroscopy. Biochim. Biophys. Acta 1580:171-188.
28. Tacconi, M. T. and Wurtman, R. J. 1985. Phosphatidylcholine produced in rat synaptosomes by N-methylation is enriched in polyunsaturated fatty acids. Proc. Natl. Acad. Sci. USA, 82:4828-4831.
29. Mozzi, R. and Porcellati, G. 1979. Conversion of phosphatidylethanolamine to phosphatidylcholine in rat brain by the methylation pathway. FEBS Lett. 100(2):363-366.
30. Bianchi, R., et al. 1999. Biochemical analysis of myelin lipids and proteins in a model of methyl donor pathway deficit: effect of S-adenosylmethionine. Exp. Neurol. 159:258-266.
31. Lambeth, J. D. and Ryu, S. H. 1996. Glycerolipids in signal transduction, Vance, D. E. and Vance, J. E. (eds.), in Biochemistry of Lipids, Lipoproteins and Membranes, Vol. Chapter 9. NY: Elsevier.
32. Harvey, B. H., et al. 2002. Defining the neuromolecular action of myo-inositol Application to obsessive-compulsive disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 26:21-32.
33. Greenberg, M. L., Hubbell, S., and Lam, C. 1988. Inositol regulates phosphatidylglycerolphosphate synthase expression in Saccharomyces cerevisiae. Mol. Cell. Biol. 8(11):4773-4779.
34. Carman, G. M. and Henry, S. A. 1999. Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processes. Prog. Lipid Res. 38:361-399.
35. Ju, S. and Greenberg, M. L. 2003. Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis. Mol. Microbiol. 49(6):1595-1603.
36. Loewen, C. J. R., et al. 2004. Phospholipid metabolism regulated by a transcription factor sensing phosphatidic acid. Science 304:1644-1647.
37. Minskoff, S. A., et al. 1994. Regulation of phosphatidic acid biosynthetic enzymes in Saccharomyces cerevisiae. J. Lipid Res. 35:2254-2262.